Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 11, 2025 • 3:21 PM ET

Date/Time Source News Release
05/01/2025 09:00 AM EDT GlobeNewswire Sonnet Chief Medical Officer, Richard Kenney, M.D., to Present at the 6th Annual Cytokine-Based Drug Development Summit
04/16/2025 09:10 AM EDT GlobeNewswire Sonnet Releases Virtual Investor "What This Means" Segment
04/04/2025 09:00 AM EDT GlobeNewswire Sonnet's SON-1010 Demonstrates a Strong Safety Profile in Combination with Atezolizumab for Treatment of Platinum-Resistant Ovarian Cancer, Including a Partial Response at the Highest Dose
04/01/2025 04:15 PM EDT GlobeNewswire Sonnet Announces Release of Corporate Update Video
04/01/2025 07:30 AM EDT GlobeNewswire Sonnet Announces the Passing of Founder and CEO Pankaj Mohan, Ph.D.
03/26/2025 09:05 AM EDT GlobeNewswire Sonnet BioTherapeutics Successfully Completes First Safety Review of SON-1010 in Combination with Trabectedin in Certain Sarcomas
03/19/2025 08:50 AM EDT GlobeNewswire Sonnet BioTherapeutics Receives Notice of Allowance for U.S. Patent Covering Composition of Matter of Specific Amino Acid Substitutions of its IL-18 Binding Protein Resistant Variant Protein
03/11/2025 08:45 AM EDT GlobeNewswire Sonnet BioTherapeutics Holdings, Inc. Participates in the Virtual Investor "Top 5 for '25" On-Demand Conference
02/26/2025 09:00 AM EST GlobeNewswire Sonnet BioTherapeutics Presents Compilation of Data Highlighting the Potential of SON-1010 as a Monotherapy or a Combination Therapy to Improve the Treatment of Solid Tumors
02/19/2025 08:35 AM EST GlobeNewswire Sonnet BioTherapeutics Announces That Its Proprietary Antibody Drug Conjugate (ADC) Platform is Available for Drug Discovery Partnerships with Potential for Producing Multiple Pipeline Drug Candidates
Page

Additional News

As of June 11, 2025 • 3:21 PM ET

Date/Time Source News Release
05/13/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Tuesday, May 13th, 2025
05/13/2025 05:31 AM EDT US Earnings Reports Expected earnings - Sonnet BioTherapeutics Holdings Inc.
04/01/2025 07:47 AM EDT SeekingAlpha Sonnet announces passing of CEO Pankaj Mohan
02/13/2025 08:42 AM EST SeekingAlpha Sonnet BioTherapeutics reports wider Q1 net loss, CFO transition
02/13/2025 08:18 AM EST SeekingAlpha Sonnet BioTherapeutics GAAP EPS of -$1.56
02/12/2025 06:00 AM EST US Earnings Reports Expected US Company Earnings on Wednesday, February 12th, 2025
02/12/2025 04:31 AM EST US Earnings Reports Expected earnings - Sonnet BioTherapeutics Holdings Inc.
12/19/2024 06:00 AM EST US Earnings Reports Expected US Company Earnings on Thursday, December 19th, 2024
12/19/2024 04:31 AM EST US Earnings Reports Expected earnings - Sonnet BioTherapeutics Holdings Inc.
12/17/2024 09:01 AM EST SeekingAlpha Sonnet BioTherapeutics GAAP EPS of -$11.35
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.